RXST

RxSight's stock price has declined significantly over the past six months. As of April 21, 2026, the share price was $7.09, a 50.49% decrease from the previous year. In Q1 2026, revenue decreased by 18.5% due to lower LDD sales. Despite beating revenue estimates and reporting a narrower loss per share, the stock fell in aftermarket trading. Analysts have a consensus "Reduce" rating with an average twelve-month price objective of $9.7778. Operating expenses are expected to be at the high end of the previously guided range due to investments in its global commercial organization.